Cytogenetic and Y chromosome microdeletion screening of a random group of infertile males

To assess whether to perform routine cytogenetic and Y chromosome microdeletion screening on all infertile male patients. A cytogenetic and Y microdeletion study of a random group of infertile men. University department. In total, 40 patients had azoospermia (21 nonidiopathic), 27 had severe oligozo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 2003-02, Vol.79 (2), p.301-307
Hauptverfasser: Quilter, Claire R, Svennevik, Elizabeth C, Serhal, Paul, Ralph, David, Bahadur, Gulam, Stanhope, Richard, Sütterlin, Marc, Delhanty, Joy D.A, Taylor, Kay E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To assess whether to perform routine cytogenetic and Y chromosome microdeletion screening on all infertile male patients. A cytogenetic and Y microdeletion study of a random group of infertile men. University department. In total, 40 patients had azoospermia (21 nonidiopathic), 27 had severe oligozoospermia/oligoasthenozoospermia (≤5 × 106/mL) (5 nonidiopathic), 20 had oligozoospermia/oligoasthenozoospermia (5–20 × 106/mL) (6 nonidiopathic), and 16 had asthenozoospermia (5 nonidiopathic). Many were candidates for intracytoplasmic sperm injection (ICSI). Collection of blood samples from all patients and buccal cells from one patient. Karyotype analysis, polymerase chain reaction (PCR) screening for Y chromosome microdeletions, and fluorescence in situ hybridization of abnormal chromosomes. Ten (9.7%) subjects, including one nonidiopathic patient, were found to have an abnormal karyotype. Two idiopathic azoospermic patients were missing large portions of Y chromosome euchromatin, confirmed by PCR analysis and an additional idiopathic azoospermic patient had a Y chromosome microdeletion. Routine cytogenetic analysis of all infertile male patients is required but it may be advisable to limit routine Y chromosome microdeletion screening to patients with severe male factor infertility (≤5 × 106/mL).
ISSN:0015-0282
1556-5653
DOI:10.1016/S0015-0282(02)04692-7